The Curbsiders Addiction Medicine is a focused podcast series that explores the clinical management of addiction and substance use disorders. Hosted by addiction medicine specialists, the podcast delivers evidence-based discussions on diagnosis, treatment strategies, harm reduction, and emerging challenges in addiction care.
Acute addiction care requires ventilation-supported naloxone use, cautious reassessment when methadone doses cannot be verified, and continuity of methadone or buprenorphine during painful illness or surgery. Flumazenil usually carries more risk than benefit after an uncertain ingestion.
Addiction medicine, toxicology and general-practice clinicians get an update on kratom, concentrated 7-hydroxymitragynine products and opioid-like dependence. Product type, total dose, dosing interval, sedative co-use, withdrawal timing, naloxone access and appropriately timed buprenorphine treatment guide assessment and harm reduction.
Alcohol use disorder pharmacotherapy is broader than naltrexone and acamprosate. The clinical focus is matching medication to the patient’s agreed goal, whether abstinence, reduced heavy-drinking days or safer consumption, while checking adherence, liver disease, renal function and co-existing symptoms.
Hospital opioid use disorder care can stall when methadone cannot be verified. The practical move is to keep treating withdrawal while confirming dose, last administration, missed doses and take-home bottles, then recognise medetomidine withdrawal when autonomic symptoms and nausea persist.
.svg)